De novo muscle invasive bladder cancer

Is there a change in trend?

Anil Vaidya, Mark S. Soloway, Chris Hawke, Rabi Tiguert, Francisco Civantos

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Purpose: We reviewed our radical cystectomy series to determine whether the majority of patients present with muscle invasive bladder cancer. Materials and Methods: The records of 184 radical cystectomies performed by 1 surgeon from 1992 to 1999 were reviewed, and all slides of presenting pathology were reviewed by 1 pathologist. The pathological stage of the tumor at presentation was noted in each case, and the number of muscle invasive tumors at presentation was compared to 2 earlier series. Results: Radical cystectomy was performed for muscle invasive transitional cell carcinoma of the bladder in 176 cases and for other histology in 8. There were 101 (57.3%) patients with muscle invasive cancer at presentation compared to 84% and 91% in the 2 earlier series, respectively, which was a statistically significant decrease (p <0.0001) in the number of de novo muscle invasive bladder cancers. Women were more likely to be diagnosed with muscle invasion primarily than men (85.2% and 50.7%, respectively), and younger patients (younger than 50 years) were more likely to present with superficial bladder cancer compared to those older than 50 years who were more likely to present with de novo muscle invasive bladder cancer. Conclusions: Analysis of our data supports the findings of the earlier series that the majority of patients present with muscle invasive bladder cancer. However, there is a significant decrease in the percentage of tumors invading the muscularis propria at presentation. Although this observation is encouraging, we emphasize that it is not as dramatic as the stage migration associated with prostate cancer, which may be largely attributed to the widespread use of prostate specific antigen for early detection. Therefore, we support the suggestion that therapeutic gains might follow from improved education regarding the signs and symptoms associated with bladder cancer, with enhanced focus on women and consideration of screening methods for those at high risk for bladder cancer.

Original languageEnglish
Pages (from-to)47-50
Number of pages4
JournalJournal of Urology
Volume165
Issue number1
StatePublished - Jan 1 2001

Fingerprint

Urinary Bladder Neoplasms
Muscles
Cystectomy
Muscle Neoplasms
Neoplasms
Transitional Cell Carcinoma
Prostate-Specific Antigen
Signs and Symptoms
Prostatic Neoplasms
Histology
Urinary Bladder
Pathology
Education

Keywords

  • Bladder neoplasms
  • Cystectomy
  • Muscles

ASJC Scopus subject areas

  • Urology

Cite this

Vaidya, A., Soloway, M. S., Hawke, C., Tiguert, R., & Civantos, F. (2001). De novo muscle invasive bladder cancer: Is there a change in trend? Journal of Urology, 165(1), 47-50.

De novo muscle invasive bladder cancer : Is there a change in trend? / Vaidya, Anil; Soloway, Mark S.; Hawke, Chris; Tiguert, Rabi; Civantos, Francisco.

In: Journal of Urology, Vol. 165, No. 1, 01.01.2001, p. 47-50.

Research output: Contribution to journalArticle

Vaidya, A, Soloway, MS, Hawke, C, Tiguert, R & Civantos, F 2001, 'De novo muscle invasive bladder cancer: Is there a change in trend?', Journal of Urology, vol. 165, no. 1, pp. 47-50.
Vaidya A, Soloway MS, Hawke C, Tiguert R, Civantos F. De novo muscle invasive bladder cancer: Is there a change in trend? Journal of Urology. 2001 Jan 1;165(1):47-50.
Vaidya, Anil ; Soloway, Mark S. ; Hawke, Chris ; Tiguert, Rabi ; Civantos, Francisco. / De novo muscle invasive bladder cancer : Is there a change in trend?. In: Journal of Urology. 2001 ; Vol. 165, No. 1. pp. 47-50.
@article{28840a7559094c519390f931865b9e8e,
title = "De novo muscle invasive bladder cancer: Is there a change in trend?",
abstract = "Purpose: We reviewed our radical cystectomy series to determine whether the majority of patients present with muscle invasive bladder cancer. Materials and Methods: The records of 184 radical cystectomies performed by 1 surgeon from 1992 to 1999 were reviewed, and all slides of presenting pathology were reviewed by 1 pathologist. The pathological stage of the tumor at presentation was noted in each case, and the number of muscle invasive tumors at presentation was compared to 2 earlier series. Results: Radical cystectomy was performed for muscle invasive transitional cell carcinoma of the bladder in 176 cases and for other histology in 8. There were 101 (57.3{\%}) patients with muscle invasive cancer at presentation compared to 84{\%} and 91{\%} in the 2 earlier series, respectively, which was a statistically significant decrease (p <0.0001) in the number of de novo muscle invasive bladder cancers. Women were more likely to be diagnosed with muscle invasion primarily than men (85.2{\%} and 50.7{\%}, respectively), and younger patients (younger than 50 years) were more likely to present with superficial bladder cancer compared to those older than 50 years who were more likely to present with de novo muscle invasive bladder cancer. Conclusions: Analysis of our data supports the findings of the earlier series that the majority of patients present with muscle invasive bladder cancer. However, there is a significant decrease in the percentage of tumors invading the muscularis propria at presentation. Although this observation is encouraging, we emphasize that it is not as dramatic as the stage migration associated with prostate cancer, which may be largely attributed to the widespread use of prostate specific antigen for early detection. Therefore, we support the suggestion that therapeutic gains might follow from improved education regarding the signs and symptoms associated with bladder cancer, with enhanced focus on women and consideration of screening methods for those at high risk for bladder cancer.",
keywords = "Bladder neoplasms, Cystectomy, Muscles",
author = "Anil Vaidya and Soloway, {Mark S.} and Chris Hawke and Rabi Tiguert and Francisco Civantos",
year = "2001",
month = "1",
day = "1",
language = "English",
volume = "165",
pages = "47--50",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - De novo muscle invasive bladder cancer

T2 - Is there a change in trend?

AU - Vaidya, Anil

AU - Soloway, Mark S.

AU - Hawke, Chris

AU - Tiguert, Rabi

AU - Civantos, Francisco

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Purpose: We reviewed our radical cystectomy series to determine whether the majority of patients present with muscle invasive bladder cancer. Materials and Methods: The records of 184 radical cystectomies performed by 1 surgeon from 1992 to 1999 were reviewed, and all slides of presenting pathology were reviewed by 1 pathologist. The pathological stage of the tumor at presentation was noted in each case, and the number of muscle invasive tumors at presentation was compared to 2 earlier series. Results: Radical cystectomy was performed for muscle invasive transitional cell carcinoma of the bladder in 176 cases and for other histology in 8. There were 101 (57.3%) patients with muscle invasive cancer at presentation compared to 84% and 91% in the 2 earlier series, respectively, which was a statistically significant decrease (p <0.0001) in the number of de novo muscle invasive bladder cancers. Women were more likely to be diagnosed with muscle invasion primarily than men (85.2% and 50.7%, respectively), and younger patients (younger than 50 years) were more likely to present with superficial bladder cancer compared to those older than 50 years who were more likely to present with de novo muscle invasive bladder cancer. Conclusions: Analysis of our data supports the findings of the earlier series that the majority of patients present with muscle invasive bladder cancer. However, there is a significant decrease in the percentage of tumors invading the muscularis propria at presentation. Although this observation is encouraging, we emphasize that it is not as dramatic as the stage migration associated with prostate cancer, which may be largely attributed to the widespread use of prostate specific antigen for early detection. Therefore, we support the suggestion that therapeutic gains might follow from improved education regarding the signs and symptoms associated with bladder cancer, with enhanced focus on women and consideration of screening methods for those at high risk for bladder cancer.

AB - Purpose: We reviewed our radical cystectomy series to determine whether the majority of patients present with muscle invasive bladder cancer. Materials and Methods: The records of 184 radical cystectomies performed by 1 surgeon from 1992 to 1999 were reviewed, and all slides of presenting pathology were reviewed by 1 pathologist. The pathological stage of the tumor at presentation was noted in each case, and the number of muscle invasive tumors at presentation was compared to 2 earlier series. Results: Radical cystectomy was performed for muscle invasive transitional cell carcinoma of the bladder in 176 cases and for other histology in 8. There were 101 (57.3%) patients with muscle invasive cancer at presentation compared to 84% and 91% in the 2 earlier series, respectively, which was a statistically significant decrease (p <0.0001) in the number of de novo muscle invasive bladder cancers. Women were more likely to be diagnosed with muscle invasion primarily than men (85.2% and 50.7%, respectively), and younger patients (younger than 50 years) were more likely to present with superficial bladder cancer compared to those older than 50 years who were more likely to present with de novo muscle invasive bladder cancer. Conclusions: Analysis of our data supports the findings of the earlier series that the majority of patients present with muscle invasive bladder cancer. However, there is a significant decrease in the percentage of tumors invading the muscularis propria at presentation. Although this observation is encouraging, we emphasize that it is not as dramatic as the stage migration associated with prostate cancer, which may be largely attributed to the widespread use of prostate specific antigen for early detection. Therefore, we support the suggestion that therapeutic gains might follow from improved education regarding the signs and symptoms associated with bladder cancer, with enhanced focus on women and consideration of screening methods for those at high risk for bladder cancer.

KW - Bladder neoplasms

KW - Cystectomy

KW - Muscles

UR - http://www.scopus.com/inward/record.url?scp=0034747659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034747659&partnerID=8YFLogxK

M3 - Article

VL - 165

SP - 47

EP - 50

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 1

ER -